Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.5894 USD
−59.08 M USD
0.00 USD
37.19 M
About Galera Therapeutics, Inc.
Sector
CEO
J. Mel Sorensen
Headquarters
Malvern
Website
Founded
2009
FIGI
BBG00QKF2H42
Galera Therapeutics, Inc. is a clinical stage biotechnology company, which engages in developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. It is also involved in the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis, and cancer. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GRTX is 0.0391 USD — it has decreased by −2.62% in the past 24 hours. Watch Galera Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Galera Therapeutics, Inc. stocks are traded under the ticker GRTX.
GRTX stock has fallen by −3.34% compared to the previous week, the month change is a −31.97% fall, over the last year Galera Therapeutics, Inc. has showed a −70.79% decrease.
GRTX reached its all-time high on Jan 7, 2020 with the price of 19.5000 USD, and its all-time low was 0.0400 USD and was reached on Nov 14, 2024. View more price dynamics on GRTX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GRTX stock is 9.97% volatile and has beta coefficient of 0.03. Track Galera Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Galera Therapeutics, Inc. there?
Today Galera Therapeutics, Inc. has the market capitalization of 2.12 M, it has decreased by −7.39% over the last week.
Yes, you can track Galera Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Galera Therapeutics, Inc. is going to release the next earnings report on Nov 25, 2024. Keep track of upcoming events with our Earnings Calendar.
GRTX earnings for the last quarter are −0.07 USD per share, whereas the estimation was 0.83 USD resulting in a −108.46% surprise. The estimated earnings for the next quarter are −0.29 USD per share. See more details about Galera Therapeutics, Inc. earnings.
GRTX net income for the last quarter is −4.06 M USD, while the quarter before that showed −4.38 M USD of net income which accounts for 7.24% change. Track more Galera Therapeutics, Inc. financial stats to get the full picture.
No, GRTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 7.00 employees. See our rating of the largest employees — is Galera Therapeutics, Inc. on this list?
Like other stocks, GRTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Galera Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Galera Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Galera Therapeutics, Inc. stock shows the sell signal. See more of Galera Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.